Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted December 1, 2022
FTC Takes Action Against Company Promoting “COVID Resist” Supplement to Treat COVID-19
On November 22, 2022, the FTC filed a complaint in a U.S. district court against California-based company Precision Patient Outcomes, Inc. for promoting its COVID Resist and VIRUS Resist supplements to prevent and treat COVID-19.
COVID Resist and VIRUS Resist contain vitamins C, D, and K, zinc, and quercetin, and were sold to consumers nationwide.
According to the official complaint, the FTC is seeking to permanently stop the company and its CEO, Margrett Priest Lewis, from using deceptive treatment and prevention claims, which lack scientific evidence, to sell dietary supplements. The agency noted that this practice violates the COVID-19 Consumer Protection Act, which allows the FTC to seek civil penalties.
Samuel Levine, Director of the Commission’s Bureau of Consumer Protection, states, “The FTC will halt baseless claims about COVID-19 treatments that harm consumers’ pocketbooks and health. We don’t simply seek to stop this kind of fraud, but to permanently prohibit companies and company owners engaging in misconduct from endangering the health and well-being of American consumers."
See ConsumerLab’s answer to the question: Do any supplements help with the coronavirus (COVID-19)? Do supplements like vitamin D, zinc, vitamin C, or herbals work?
For more information, use the link below.
FTC Acts to Stop Deceptive COVID-19 Advertising Claims by California’s Precision Patient Outcomes, Inc.
See related recalls and warnings:
FTC, FDA, and DOJ Take Joint Action Against Herbal Tea Companies for COVID Claims
Complaint Submitted to FTC for doTerra Essential Oil COVID Claims
Natural Solutions Foundation Banned From Selling "Nano Silver" as COVID Treatment
Unauthorized Rapid Antigen Test Gets FDA Warning
Chiropractor Who Claimed Vitamin D and Zinc Work Better Than COVID Vaccines Charged by FTC